Ironwood Pharmaceuticals

IRWDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$711.130 M

$4.32 +1.41%

Close of 7 Aug 2026

Revenue

$296.2M

#2143 by revenue

Earnings

$24.0M

#1814 by earnings

Shares outstanding

165,239,947

Latest filing cover page

P/E ratio

29.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#186CybinHELP$719.6M
#187Evotec SEEVO$711.5M
#188Ironwood PharmaceuticalsIRWD$711.1M
#189Phathom PharmaceuticalsPHAT$691.7M
#190Zevra TherapeuticsZVRA$686.5M

Where these numbers come from

Share counts and financials for Ironwood Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.